Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Sunday, 21 April 2024
JNCE
NASDAQ
JNCE
Summary
|
Chart
|
News
|
History
|
More info..
NASDAQ : JNCE
1.970
14 Oct 22 00:00
Change:
0.16
Open:
2.160
High:
2.200
Ask:
0.000
Volume:
285,500
Change(%):
7.51
Prev:
2.130
Low:
1.970
Bid:
0.000
Avg vol:
0
Latest News
More news...
Focusing The Lens on Shares Jounce Therapeutics Inc (JNCE)
23:18 | 20/2/18
Jonesboro Recorder
Shares of Jounce Therapeutics Inc (JNCE) are nearing some key technical levels as the Rank Correlation indicator has trending higher over the past few sessions, nearing potential overbought territory.
more»
First Manhattan Co. Buys 47000 Shares of Jounce Therapeutics Inc (JNCE)
15:48 | 20/2/18
StockNewsTimes
Jounce Therapeutics logo First Manhattan Co. grew its position in Jounce Therapeutics Inc (NASDAQ:JNCE) by 151.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).
more»
Jounce Therapeutics Inc (JNCE) Shares Bought by Schwab Charles Investment ...
17:41 | 18/2/18
StockNewsTimes
Jounce Therapeutics logo Schwab Charles Investment Management Inc. raised its position in Jounce Therapeutics Inc (NASDAQ:JNCE) by 71.1% during the third quarter, according to its most recent 13F filing with the SEC.
more»
EPS for Jounce Therapeutics, Inc. (JNCE) Expected At $-0.59
11:41 | 18/2/18
BZ Weekly
Analysts expect Jounce Therapeutics, Inc. (NASDAQ:JNCE) to report $-0.59 EPS on March, 9.They anticipate $0.64 EPS change or 1,280.00 % from last quarter's $0.05 EPS.
more»
Comparing Jounce Therapeutics (NASDAQ:JNCE) and Its Peers
03:03 | 18/2/18
The Ledger Gazette
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients ...
more»
Comments
There are currently no comments on this topic.
Be the first person to Add a Comment...
ADD USER TO MY FAVOURITE
Customize your favourite:
Send me an alert when this user publishes new articles.
Add a Comment
You must be a registered user to post a comment:
REGISTER NOW
If you are already registered, please
LOGIN NOW
Add to Watchlist
Add to Portfolio
Add Email Alert
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
Most Viewed Stories
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%
Newsletters
Email Address:
Weekly Newsletter
Daily Market Report
Daily Forex Report
Daily Global Report